276 related articles for article (PubMed ID: 19460280)
1. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE; Garcia RL
J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
[TBL] [Abstract][Full Text] [Related]
2. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
[TBL] [Abstract][Full Text] [Related]
3. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
4. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
5. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
Gupta N; Dudding N; Smith JH
Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
[TBL] [Abstract][Full Text] [Related]
6. Heterologous type of malignant mixed Müllerian tumor of the uterus presenting as a vulvar mass.
Grigore M; Ilea C; Terinte C; Sava A; Popovici R
Eur J Gynaecol Oncol; 2014; 35(4):458-60. PubMed ID: 25118493
[TBL] [Abstract][Full Text] [Related]
7. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
[TBL] [Abstract][Full Text] [Related]
8. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
9. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
10. Uterine Adenosarcoma.
Pinto A; Howitt B
Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
[TBL] [Abstract][Full Text] [Related]
11. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.
Jin Z; Ogata S; Tamura G; Katayama Y; Fukase M; Yajima M; Motoyama T
Int J Gynecol Pathol; 2003 Oct; 22(4):368-73. PubMed ID: 14501818
[TBL] [Abstract][Full Text] [Related]
12. Carcinosarcoma (malignant mixed müllerian tumor) of the uterus with a rhabdoid tumor component. An immunohistochemical, ultrastructural, and immunoelectron microscopic case study.
Mount SL; Lee KR; Taatjes DJ
Am J Clin Pathol; 1995 Feb; 103(2):235-9. PubMed ID: 7856569
[TBL] [Abstract][Full Text] [Related]
13. Uterine carcinosarcoma (malignant mixed Müllerian tumor): case report in a goat and literature review.
Cossic B; Hill JA; Cercone M; Southard T
J Vet Diagn Invest; 2018 Nov; 30(6):955-961. PubMed ID: 30345891
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
Pinto A; Mackrides N; Nadji M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas.
McCluggage WG
Int J Gynecol Cancer; 2002; 12(6):687-90. PubMed ID: 12445244
[TBL] [Abstract][Full Text] [Related]
16. [Malignant mixed Müllerian tumor of the urinary bladder].
Schildhaus HU; Mikuz G; Fisang C; Steiner S; Büttner R; Wardelmann E
Pathologe; 2008 Sep; 29(5):375-7. PubMed ID: 18592241
[TBL] [Abstract][Full Text] [Related]
17. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
Horn LC; Dallacker M; Bilek K
Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
[TBL] [Abstract][Full Text] [Related]
18. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
[TBL] [Abstract][Full Text] [Related]
19. Pathologic and molecular features of uterine carcinosarcomas.
Lopez-Garcia MA; Palacios J
Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide antigen production in a uterine carcinosarcoma cell line in a serum-free culture.
Emoto M; Iwasaki H; Kikuchi M; Shirakawa K
Gynecol Oncol; 1996 Mar; 60(3):443-9. PubMed ID: 8774655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
